IPP Bureau
Sumitomo Dainippon Pharma Oncology appoints Jatin J. Shah as Chief Medical Officer
By IPP Bureau - February 23, 2022
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Hovione and Zerion Pharma partner to market Dispersome technology platform
By IPP Bureau - February 23, 2022
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control
By IPP Bureau - February 23, 2022
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
Taro to Acquire Alchemee from Galderma
By IPP Bureau - February 23, 2022
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
GSK introduces Haleon to the world
By IPP Bureau - February 23, 2022
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Carestream India launches digital radiology solution 'DRX Compass'
By IPP Bureau - February 23, 2022
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
Zydus receives USFDA approval for Dapagliflozin tablets
By IPP Bureau - February 23, 2022
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
Bajaj Healthcare launches Magnesium L-Threonate in nutraceutical segment.
By IPP Bureau - February 23, 2022
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
ACUITE upgrades ratings of Bal Pharma
By IPP Bureau - February 23, 2022
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Dr Fabrice Egros gets an additional role at Lupin
By IPP Bureau - February 23, 2022
He will continue to lead business in LATAM and Asia regions in this new role
Complement Therapeutics raises €5 million seed financing
By IPP Bureau - February 23, 2022
Appoints Dr Rafiq Hasan as CEO
Biorchestra announces US$45 million series C fundraising
By IPP Bureau - February 23, 2022
he financing was significantly oversubscribed with high demand from both existing and new investors.
Vicore advances on new chemical entity from VP03 program
By IPP Bureau - February 23, 2022
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
By IPP Bureau - February 23, 2022
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Moderna and Thermo Fisher Scientific to deepen mRNA collaboration
By IPP Bureau - February 23, 2022
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
